Compare CCC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCC | AMRX |
|---|---|---|
| Founded | 1980 | 2002 |
| Country | United States | United States |
| Employees | 2185 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | N/A | 2018 |
| Metric | CCC | AMRX |
|---|---|---|
| Price | $4.78 | $12.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $8.94 | ★ $15.60 |
| AVG Volume (30 Days) | ★ 9.0M | 1.4M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.22 | $4.48 |
| Revenue Next Year | $8.58 | $7.13 |
| P/E Ratio | ★ N/A | $57.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.68 | $7.02 |
| 52 Week High | $8.68 | $15.42 |
| Indicator | CCC | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 49.87 |
| Support Level | N/A | $12.50 |
| Resistance Level | $6.34 | $12.85 |
| Average True Range (ATR) | 0.29 | 0.49 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 15.75 | 30.56 |
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.